Method for detecting a radical compound derived from a lipid and a compound derived from the radical compound
US-2018328951-A1 · Nov 15, 2018 · US
US11725002B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11725002-B2 |
| Application number | US-201816609028-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 27, 2018 |
| Priority date | Apr 28, 2017 |
| Publication date | Aug 15, 2023 |
| Grant date | Aug 15, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A detection reagent for comprehensively detecting an oxidized state and a glycated state of a low-density lipoprotein. While an oxidized low-density lipoprotein and a glycated low-density lipoprotein are detected with a fluolophore-labelled antibody, a lipid radical is detected with a fluorescent nitroxide 2,2,6-trimethyl-4-(4-nitrobenzo[1,2,5]oxadiazol-7-ylamino)-6-pentylpiperadine-1-oxyl (NBD-Pen).
Opening claim text (preview).
The invention claimed is: 1. A detection reagent containing a primary detection antibody recognizing an oxidized low-density lipoprotein, a primary detection antibody recognizing a glycated low-density lipoprotein, a secondary antibody recognizing the primary detection antibody recognizing the oxidized low-density lipoprotein, a secondary antibody recognizing the primary detection antibody recognizing the glycated low-density lipoprotein, wherein the secondary antibody recognizing the primary detection antibody recognizing the oxidized low-density lipoprotein and the secondary antibody recognizing the primary detection antibody recognizing glycated low-density lipoprotein are fluorescently labelled with fluorophores, and a fluorescent nitroxide represented by the chemical structure (1): 2. The detection reagent according to claim 1 , wherein the primary detection antibody recognizing the oxidized low-density lipoprotein is a mixture containing at least an antibody recognizing malondialdehyde lysine, an antibody recognizing 4-hydroxy-2-nonenal lysine, and an antibody recognizing acrolein lysine. 3. The detection reagent according to claim 1 , wherein the primary detection antibody recognizing the glycated low-density lipoprotein is a mixture containing at least an antibody recognizing pentosidin, an antibody recognizing crossline, an antibody recognizing (Nε-carboxymethyl)lysine, an antibody recognizing (Nε-carboxyethyl)lysine, and an antibody recognizing pyrraline. 4. A kit for identifying an oxidized state and a glycated state of a low-density lipoprotein, which includes a microplate on which an antibody recognizing a low-density lipoprotein is immobilized, and the detection reagent according to claim 1 . 5. The kit according to claim 4 , wherein at least one of the fluorophores is a 7-nitrobenzofurazan derivative. 6. The kit according to claim 4 , wherein the fluorophores have emission wavelengths different from each other. 7. The kit according to claim 4 , wherein the secondary antibody recognizing the primary detection antibody recognizing the oxidized low-density lipoprotein and the secondary antibody recognizing the primary detection antibody recognizing the glycated low-density lipoprotein are each fluorescently labelled with a fluorophore which is excited with an excitation wavelength of 485 nm and observed fluorescent intensity at 528 nm. 8. The detection reagent according to claim 1 , wherein the fluorophores have emission wavelengths different from each other. 9. The detection reagent according to claim 1 , wherein the secondary antibody recognizing the primary detection antibody recognizing the oxidized low-density lipoprotein and the secondary antibody recognizing the primary detection antibody recognizing the glycated low-density lipoprotein are each fluorescently labelled with a fluorophore which can be excited with an excitation wavelength at 485 nm and observed fluorescent intensity at 528 nm.
linked by a chain containing hetero atoms as chain links · CPC title
against material from animals or humans · CPC title
Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" (in vivo A61B5/00; immunoassay G01N33/53) · CPC title
producing a change of colour · CPC title
with fluorescent label · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.